Delivery Order 75D30123D18241-75D30124F00003
Award Date
9/27/24
Potential Completion Date
9/26/27
Potential Value
$1.5M
Federal Agency
CDC Pittsburgh
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
622110 - General Medical and Surgical Hospitals
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Duke University was awarded a $2,031,493.71 firm fixed price contract by the Centers for Disease Control and Prevention (CDC) to support Topic 2 of the FY 2020 COVID-19 Broad Agency Announcement. Performance will take place in Atlanta, GA through December 31, 2022. As prime contractor, Duke University will provide clinical research and immunization safety assessment services to the CDC under this award. The Institute for Medical Research, Inc., a nonprofit research organization supporting work...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Duke University for the "LEAD SITE OPTIONAL TASK 1: BABIES COVID-19 VACCINATION" as a Delivery Order under the existing Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $970,063.00 and a period of performance through December 28, 2025. Duke University, a private university and non-profit...
This contract was awarded to Duke University by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) as a delivery order against the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) IDIQ contract. The contract has a firm fixed price of $1,947,688.74 and a completion date of May 31, 2022. It is not set aside for any socioeconomic program. As the prime contractor, Duke University is providing clinical research and...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a prominent private research university. The contract, with a ceiling value of $2,488,592.00, is for a research safety study on the SHINGRIX vaccine. The contract is a delivery order under the larger Clinical Immunization Safety Assessment (CISA) indefinite delivery vehicle (IDV) with the CDC. The award has no set-aside designation. Duke University has a robust track record of receiving...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a private university and non-profit organization, to provide clinical research and immunization safety assessment services. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $465,451.00 and was awarded on September 29, 2015, with a completion date...
Duke University Office of Research Administration Division was awarded a cost-no-fee delivery order against a Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC). The $8.3 million delivery order is to support pediatric trials conducted by the National Institutes of Health's National Institute of Child Health and Human Development. As the prime contractor, Duke University will provide...
The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, to provide services as a contributing site for a study conducted by the Centers for Disease Control and Prevention (CDC) on Respiratory Syncytial Virus (RSV) in infants. The contract has a ceiling value of $781,590.89 and a period of performance through September 26, 2027. The contract type is a Delivery Order, with a Pricing Type of Cost No Fee. Emory University, through its Office of...
This is a definitive federal contract awarded by the U.S. government to Duke University's Office of Research Administration Division as the prime contractor. The $3,252,484.82 contract is for biomedical research and exploratory development services, with no set-aside designation used. The contract appears to be part of a larger indefinite delivery/indefinite quantity (IDIQ) vehicle awarded to Duke by the Centers for Disease Control and Prevention (CDC) to provide clinical research and...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...